SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-032548
Filing Date
2024-02-12
Accepted
2024-02-12 21:06:27
Documents
2
Group Members
NAN FUNG GROUP HOLDINGS LTDNAN FUNG LIFE SCIENCES HOLDINGS LTDNF INVESTMENT HOLDINGS LTDNFLS BETA LTDNFLS PLATFORM HOLDINGS LTDNFLS ZETA LTDPIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD.PIVOTAL LIFE SCIENCES HO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d751446dsc13ga.htm SC 13G/A 168473
2 EX-99.1 d751446dex991.htm EX-99.1 15372
  Complete submission text file 0001193125-24-032548.txt   185945
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94014 | Film No.: 24622289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)